Journey Medical (DERM) Proxy filing summary

Executive summary

• Annual Meeting scheduled for June 24, 2026, will be held virtually to encourage broader participation and reduce costs and environmental impact.

• Stockholders will vote on electing six directors for a one-year term and ratifying KPMG LLP as the independent auditor for 2026.

• Proxy materials are available online, and voting can be done via internet, mobile device, or mail.

• Only stockholders of record as of April 28, 2026, are entitled to vote.

Voting matters and shareholder proposals

• Proposals include electing six directors and ratifying KPMG LLP as the independent auditor.

• Board unanimously recommends voting FOR all director nominees and FOR auditor ratification.

• Stockholders may submit proposals for the 2027 meeting by December 30, 2026.

Board of directors and corporate governance

• Board consists of six members, four of whom are independent.

• No standing risk management committee; risk oversight is handled by the full Board and its committees.

• Audit and Compensation Committees are established and comply with SEC and Nasdaq requirements.

• No nominating committee; independent directors recommend nominees.

• Code of Business Conduct and Ethics and Insider Trading Policy are in place.